Ara
Toplam kayıt 5, listelenen: 1-5
Evaluating the effect of tumor size and sidedness on prognosis in stage 2 colon cancer: a retrospective population study
(Verduci, 2022)
OBJECTIVE: In this study, we aimed to evaluate the effect of tumor size and tumor sidedness on prognosis in patients with stage 2 colon cancer.
PATIENTS AND METHODS: Data of 501 patients diagnosed with stage 2 colon cancer ...
The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG Study
(Springer, 2021)
Purpose Colorectal cancer is the third leading diagnosis accounting for nearly 10% of all new cancers worldwide. The distinct features among BRAF mutant colorectal cancers make these tumor groups hard to treat for oncologists. ...
Prognostic role of pre-operative serum ferritin level in stage 2 colon cancer
(Verduci, 2021)
OBJECTIVE: In this study, we aimed to evaluate the prognostic value of preoperative serum ferritin level in patients with stage 2 colon cancer who underwent curative surgery.
PATIENTS AND METHODS: The data of 120 patients ...
A New Prognostic Index in Young Breast Cancer Patients
(College of Physicians and Surgeons Pakistan, 2022)
Objective:To evaluate the prognostic role of pan immune-inflammation value (PIV) in young breast cancer patients.
Study Design: Descriptive study.
Place and Duration of Study: Department of Medical Oncology, Afyon ...
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study
(Lippincott, Williams & Wilkins, 07.06.2022)
In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted ...